Maximum quantity allowed is 999
Please select the quantity
CAS RN: 27724-96-5 | Product Number: C3454
Cetraxate Hydrochloride
Purity: >98.0%(T)(HPLC)
Synonyms:
- 3-[4-[[trans-4-(Aminomethyl)cyclohexyl]carbonyloxy]phenyl]propanoic Acid Hydrochloride
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
250MG |
$246.00
|
3 | 1 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Product Number | C3454 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__7H__2__3NO__4·HCl = 341.83 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 27724-96-5 |
Related CAS RN | 34675-84-8 |
Reaxys Registry Number | 5681006 |
PubChem Substance ID | 354334777 |
Merck Index (14) | 2024 |
MDL Number | MFCD01722166 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
NMR | confirm to structure |
Properties (reference)
Melting Point | 240 °C |
GHS
Related Laws:
Transport Information:
H.S.code* | 2922.49-000 |
Application
Cetraxate Hydrochloride: A Gastrointestinal Agent with a Cytoprotective Effect
Cetraxate hydrochloride is a gastrointestinal agent which has a cytoprotective effect. It is reported that cetraxate increased gastric mucosal blood flow and inhibited the ulcerogenic action of acetylsalicylic acid [A2262], phenylbutazone [P1686], indomethacin [I0655], et al. (The product is for research purpose only.)
References
- Anti-ulcer effects of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats
- Studies on the mechanism of action of cetraxate [4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride], a new anti-ulcer agent
- Cytoprotective action of cetraxate against hydrochloric acid·ethanol-induced gastric lesion in rats
- Influence of Helicobacter pylori infection and cetraxate on gastric mucosal blood flow during healing of endoscopic mucosal resection-induced ulcers
Application
Cetraxate Hydrochloride: An Antiulcer and Anti-Gastritis Agent
Cetraxate hydrochloride is an antiulcer and anti-gastritis agent which has a cytoprotective effect. It produces a dose-related increase in mucosal blood flow. In addition, it is reported that cetraxate is effective for the eradication of Helicobacter pylori infection. (The product is for research purpose only.)
References
- Anti-ulcer effects of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexanecarboxylate hydrochloride (cetraxate) on various experimental gastric ulcers in rats
- Oxyradical generation from leukocytes during endotoxin-induced microcirculatory disturbance in rat mesentery. Attenuating effect of cetraxate
- Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of Helicobacter pylori in smokers
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.